Literature DB >> 6406638

H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus.

W J Britt, B Chesebro.   

Abstract

A Friend virus (FV)-specific T lymphocyte proliferation assay was used to compare the T lymphocyte responses of H-2 congenic mice that differed in their ability to recover from FV leukemia after inoculation of high virus doses. Gene(s) of the H-2D region influenced the kinetics of this response such that H-2Db/b homozygous mice were positive 6-8 d earlier than H-2Dd/b mice. This correlated with the Rfv-1, H-2D-linked influence on recovery from FV by these mice, and also appeared to explain the prominent effect of virus dose on recovery incidence. These findings were supported by the ability of passively transferred immune splenic T lymphocytes to induce recovery from leukemia at 6 d after FV inoculation, but not at 16 d. H-2a/a mice were found to be unresponsive in the FV-specific T lymphocyte proliferation assay. This effect mapped to the left of H-2D, possibly in the H-2I region, and may be an in vitro manifestation of the Rfv-2 gene. No evidence for nonspecific immunosuppression of the T lymphocyte response to concanavalin A was observed in any of the H-2 congenic F1 mice studied.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406638      PMCID: PMC2187025          DOI: 10.1084/jem.157.6.1736

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  In vitro depression of cellular immunity by Friend virus leukemic spleen cells.

Authors:  S T Toy; E F Whellock
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

2.  Mechanisms of the H-2 effect on viral leukemogenesis.

Authors:  J E Bubbers; K J Blank; H A Freedman; F Lilly
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

Review 3.  Immunodepression by oncogenic viruses.

Authors:  P B Dent
Journal:  Prog Med Virol       Date:  1972

4.  A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media.

Authors:  A B Peck; F H Bach
Journal:  J Immunol Methods       Date:  1973-10       Impact factor: 2.303

5.  Immunodepression and malignancy.

Authors:  O Stutman
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

6.  The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.

Authors:  D C Shreffler; C S David
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

7.  Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity.

Authors:  K J Blank; F Lilly
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

8.  Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.

Authors:  B Chesebro; K Wehrly
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

9.  Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.

Authors:  V Kumar; T Caruso; M Bennett
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

10.  Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.

Authors:  B Chesebro; K Wehrly; J Stimpfling
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  21 in total

1.  Susceptibility to a mouse acquired immunodeficiency syndrome is influenced by the H-2.

Authors:  D Hamelin-Bourassa; E Skamene; F Gervais
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 2.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.

Authors:  K E Peterson; M Iwashiro; K J Hasenkrug; B Chesebro
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity.

Authors:  B Chesebro; K Wehrly
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

5.  Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Authors:  R Yarchoan; H G Guo; M Reitz; A Maluish; H Mitsuya; S Broder
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.

Authors:  K J Hasenkrug; D M Brooks; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency.

Authors:  W R Green; K A Green; K M Crassi
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.

Authors:  Karin E Peterson; Ingunn Stromnes; Ron Messer; Kim Hasenkrug; Bruce Chesebro
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice.

Authors:  A S Apt; V G Avdienko; B V Nikonenko; I B Kramnik; A M Moroz; E Skamene
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

10.  Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice.

Authors:  M N Robertson; G J Spangrude; K Hasenkrug; L Perry; J Nishio; K Wehrly; B Chesebro
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.